Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Item 9 Labs (INLB) Payables (2016 - 2023)

Item 9 Labs' Payables history spans 13 years, with the latest figure at $36.4 million for Q2 2023.

  • For Q2 2023, Payables rose 300.36% year-over-year to $36.4 million; the TTM value through Jun 2023 reached $36.4 million, up 300.36%, while the annual FY2022 figure was $29.6 million, 27.13% up from the prior year.
  • Payables reached $36.4 million in Q2 2023 per INLB's latest filing, up from $10.0 million in the prior quarter.
  • In the past five years, Payables ranged from a high of $36.4 million in Q2 2023 to a low of $54424.0 in Q2 2019.
  • Average Payables over 5 years is $14.1 million, with a median of $8.2 million recorded in 2020.
  • Peak YoY movement for Payables: skyrocketed 4171.98% in 2020, then tumbled 62.3% in 2023.
  • A 5-year view of Payables shows it stood at $2.6 million in 2019, then skyrocketed by 85.97% to $4.8 million in 2020, then skyrocketed by 473.58% to $27.6 million in 2021, then fell by 0.1% to $27.6 million in 2022, then skyrocketed by 31.79% to $36.4 million in 2023.
  • Per Business Quant, the three most recent readings for INLB's Payables are $36.4 million (Q2 2023), $10.0 million (Q1 2023), and $27.6 million (Q4 2022).